Merck & Co. Inc. (NYSE:MRK) as well as Sanofi Pasteur, the vaccines division of Sanofi (SNY) released that the BLA filed for the firm' investigational pediatric hexavalent vaccine, DTaP5-IPV-Hib-HepB1, has been received for review by the U.S. FDA. If approved, it would be the first pediatric combination vaccine in the U.S. designed to assist protect against 6 important diseases diphtheria, tetanus, pertussis (whooping cough), polio (poliovirus types 1, 2, and 3), invasive disease caused by Haemophilus influenzae type b (Hib), and hepatitis B. Shares of Merck & Co. Inc. (NYSE:MRK) traded at $54.05 by surging 0.06% with price volatility of 2.17% for a week and 1.90% for a month. Its beta stands at 0.46 times.Steven Madden, Ltd. (NASDAQ:SHOO) reported that it cut its outlook for third quarter (Sep), sees EPS of $0.61-0.62 as compared to $0.67 Capital IQ Consensus Estimate; sees third quarter (Sep) revs of $392 million as compared to $415.39M Capital IQ Consensus Estimate. Factoring in the currently purchase of Dolce Vita and preset anticipations for the remainder of the year, for fiscal year 2014, the Company now anticipates that net sales will increase 1% to 2% over net sales in 2013 (+5% consensus). Steven Madden, Ltd. (NASDAQ:SHOO) stock hit highest price at $29.41, beginning with a price of $29.21 and reported a lose of -9.61% to the closed at $28.87 with a day range of $28.02-$29.41. The total market capitalization remained 1.884 Billion, total volume of 2.78 Million shares held in the session was surprisingly higher than its average volume of 546.94 shares.Takeda Pharmaceutical Company Limited (TKPYY), its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. along with Orexigen Therapeutics, Inc. (NASDAQ:OREX) jointly declared that Contrave (naltrexone HCI and bupropion HCI) extended-release tablets are now available to patients by prescription in pharmacies across the United States. Orexigen Therapeutics, Inc. (NASDAQ:OREX) stock has highest price of $4.23 in last session, beginning with a price of $4.08 and reported a lose of -0.49% to the closed at $4.06 with a day range of $4.02-$4.23. The stock is going forward its 52-week low with 30.55% and moving down from its 52 week high price with -48.08%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
